Bizarre Patents
Microwave Oven With Removable Storage Cassette in Dashboard of Motor Vehicle
A microwave oven adapted for use within a motor vehicle dashboard area. The microwave oven has a removable storage cassette, and slidable platforms for securing and serving containers of beverages and foods.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20090246225 | Methods of Producing Influenza Vaccine Compositions Methods and compositions for the optimization of production of influenza viruses suitable as influenza vaccines are provided.... | 10/01/2009 |
| 20090221803 | MODULATION OF ANTIBODY EFFECTOR FUNCTION BY HINGE DOMAIN ENGINEERING The present invention relates to novel molecules (Fc variants) comprising at least one antigen binding region and an Fc region that further comprises a modified hinge which alters the binding of Fc to one or more Fc ligand (e.g., FcγRs) and/or modulates effector functi... | 09/03/2009 |
| 20090220527 | AFFINITY OPTIMIZED EPHA2 AGONISTIC ANTIBODIES AND METHODS OF USE THEREOF The present invention relates to antibodies with increased affinities that preferentially bind an EphA2 epitope exposed on cancer cells but not non-cancer cells. The present invention further relates to methods and compositions designed for the treatment, management, or... | 09/03/2009 |
| 20090208532 | Methods Of Producing Influenza Vaccine Compositions Methods and compositions for the optimization and production of influenza viruses, e.g., ca influenza B strains, in eggs and host cells suitable as influenza vaccines are provided.... | 08/20/2009 |
| 20090208527 | MULTI PLASMID SYSTEM FOR THE PRODUCTION OF INFLUENZA VIRUS Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided. Additionally, the invention ... | 08/20/2009 |
| 20090186038 | Methods of Preventing or Treating Respiratory Conditions The present invention provides prophylactic an therapeutic protocols designed to prevent, manage, treat, or ameliorate a respiratory condition or one or more symptoms thereof. In particular, the present invention provides methods for preventing, managing, treating, or a... | 07/23/2009 |
| 20090175909 | Influenza Hemagglutinin And Neuraminidase Variants Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.... | 07/09/2009 |
| 20090175908 | Influenza Hemagglutinin And Neuraminidase Variants Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.... | 07/09/2009 |
| 20090175907 | Multi Plasmid System For The Production Of Influenza Virus Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided. Additionally, the invention ... | 07/09/2009 |
| 20090175899 | RECOMBINANT RSV VIRUS EXPRESSION SYSTEMS AND VACCINES The present invention relates to genetically engineered recombinant RS viruses and viral vectors which contain heterologous genes which for the use as vaccines. In accordance with the present invention, the recombinant RS viral vectors and viruses are engineered to cont... | 07/09/2009 |
| 20090175898 | Influenza Hemagglutinin And Neuraminidase Variants Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.... | 07/09/2009 |
| 20090169546 | HIGH AFFINITY ANTIBODIES AGAINST HMGB1 AND METHODS OF USE THEREOF Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically b... | 07/02/2009 |
| 20090162933 | EPHA2 AND HYPERPROLIFERATIVE CELL DISORDERS The present invention relates to methods and compositions designed for the treatment, management, or prevention of a non-neoplastic hyperproliferative cell or excessive cell accumulation disorders, particularly those involving hyperproliferation of epithelial or endothe... | 06/25/2009 |
| 20090155275 | MULTISPECIFIC EPITOPE BINDING PROTEINS AND USES THEREOF The present invention relates to multispecific epitope binding proteins, methods of making, and uses thereof in the prevention, management, treatment or diagnosis of acute or chronic diseases.... | 06/18/2009 |
| 20090148459 | Prevention or Treatment of Cancer Using Integrin alphavbeta3 Antagonists in Combination with Other Agents The present invention relates to methods and compositions designed for the treatment, management or prevention of cancer. The methods of the invention comprise the administration of an effective amount of one or more antagonists of Integrin αVβ3 ... | 06/11/2009 |
| 20090136530 | Influenza Hemagglutinin and Neuraminidase Variants Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided.... | 05/28/2009 |
| 20090130111 | Method of Identifying Membrane Ig Specific Antibodies and Use Thereof for Targeting Immunoglobulin-Producing Precursor Cells The present invention relates to the discovery of antibodies that bind to novel epitopes present on membrane-anchored immunoglobulins and which bind to these novel epitopes on the surface of B cells and plasma cells. In addition, the antibodies of the present invention ... | 05/21/2009 |
| 20090117150 | Functional Mutations In Respiratory Syncytial Virus The present invention provides recombinant respiratory syncytial viruses that have an attenuated phenotype and that comprise one or more mutations in the viral P, M2-1 and/or M2-2 proteins, as well as live attenuated vaccines comprising such viruses and nucleic acids en... | 05/07/2009 |
| 20090104205 | Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus This invention relates to a human antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody, against respiratory syncytial virus which is MAb1129 and the use thereof for the prevention and/or treatme... | 04/23/2009 |
| 20090053238 | Stabilized High Concentration Anti-Integrin alphavbeta3 Antibody Formulations The present invention provides liquid formulations of antibodies or antibody fragments that immunospecifically bind to integrin αVβ3, which formulations exhibit stability, low to undetectable levels of aggregation, and very little to no loss of t... | 02/26/2009 |
| 20090053234 | Methods of Preventing or Treating Inflammatory or Autoimmune Disorders by Administering Integrin ALPHAVBETA3 Antogonists in Combination with other Prophylactic or Therapeutic Agents The present invention provides to methods of preventing, treating or ameliorating one or more symptoms associated with an autoimmune or inflammatory disorder utilizing combinatorial therapy. In particular, the present invention provides methods of preventing, treating, ... | 02/26/2009 |
| 20090047277 | RECOMBINANT IL-9 ANTIBODIES AND USES THEREOF The present invention provides novel antibodies that immunospecifically bind to an IL-9 polypeptide and compositions comprising said antibodies. The present invention also provides methods and compositions preventing, treating, managing, and/or ameliorating diseases and... | 02/19/2009 |
| 20090017517 | Preparation of Negative-Stranded RNA Viruses by Electroporation The present invention encompasses methods of preparing non-segmented negative-stranded RNA viruses from cells utilizing electroporation.... | 01/15/2009 |
| 20090004722 | Recombinant Parainfluenza Virus Expression Systems And Vaccines The present invention relates to recombinant bovine parainfluenza virus (bPIV) cDNA or RNA which may be used to express heterologous gene products in appropriate host cell systems and/or to rescue negative strand RNA recombinant viruses that express, package, and/or pre... | 01/01/2009 |
| 20080311122 | Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically b... | 12/18/2008 |
| 20080305120 | Immunogenic Compositions Comprising Hmgb 1 Polypeptides The present invention relates to novel immunogenic compositions (e.g., vaccines), the production of such immunogenic compositions and methods of using such compositions. More specially, this invention provides unique immunogenic molecules comprising an HMGB1 polypeptide... | 12/11/2008 |
| 20080299134 | Recombinant Anti-Interleukin-9 Antibodies The application describes neutralizing chimeric and humanized anti-human IL-9 antibodies, and the use thereof to identify neutralizing epitopes on human IL-9 and as medicaments to prevent and treat asthma, bronchial hyperresponsiveness, atopic allergy, and other related... | 12/04/2008 |
| 20080286850 | MDCK CELL LINES SUPPORTING VIRAL GROWTH TO HIGH TITERS AND BIOREACTOR PROCESS USING THE SAME The present invention relates to novel MDCK cells which can be to grow viruses, e.g., influenza viruses, in cell culture to higher titer than previously possible. The MDCK cells can be adapted to serum-free culture medium. The present invention further relates to cell c... | 11/20/2008 |
| 20080279851 | ANTI-ICOS ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE The present invention provides anti-human ICOS antibodies with increased effector function. The invention further relates to pharmaceutical compositions, immunotherapeutic compositions, and methods using therapeutic antibodies that bind to the human ICOS antigen and tha... | 11/13/2008 |
| 20080279892 | Recombinant RSV Virus Expression Systems And Vaccines The present invention relates to genetically engineered recombinant respiratory syncytial viruses and viral vectors which contain deletions of various viral accessory gene(s) either singly or in combination. In accordance with the present invention, the recombinant resp... | 11/13/2008 |
